Investment Summary |
|
|---|---|
| Date | 2017-10-30 |
| Target | Crown Laboratories |
| Sector | Life Science |
| Investor(s) |
Hildred Capital Partners
Montreux Equity Partners |
| Deal Type | Growth Capital |
| Advisor(s) | Torreya Partners LLC (Financial) Michael Best & Friedrich (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Hildred Capital Partners is a family backed investment firm focused on active and passive investments across a range of securities. The Firm does not have any geographic preferences and will consider both equity and debt investing. Hildred Capital Partners was formed in 2014 and is headquartered in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 3 |
| Sector (Life Science) | 2 of 3 |
| Type (Growth Capital) | 2 of 2 |
| State (Tennessee) | 1 of 1 |
| Country (United States) | 2 of 2 |
| Year (2017) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-09-06 |
Pharmaceutics International
Hunt Valley, Maryland, United States Pharmaceutics International is a privately held contract development and manufacturing organization providing dosage form development and manufacturing services to the global pharmaceutical industry. Pharmaceutics International provides services that include preformulation testing, formulation development, clinical and commercial CGMP manufacturing of solid, parenteral, inhalation, semi-solid and liquid dosage forms, clinical packaging and labeling, and analytical services. Pharmaceutics International was founded in 1994 and is based in Hunt Valley, Maryland. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-11-30 |
GlaxoSmithKline - Consumer Healthcare Portfolio
Brentford, United Kingdom GlaxoSmithKline plc - Consumer Healthcare Portfolio has long been regarded as high quality, safe and effective, maintaining a quality image and loyal base of consumers. OTC medications allow practitioners and their patients the ability to access therapeutic products while reducing the burden of prescription drug costs on the healthcare system. The products expand Crown Laboratories’ consumer portfolio by adding #1 in category brands that treat multiple conditions. The acquired portfolio includes PanOxyl®: #1 Dermatologist recommended daily acne wash Sarna®: #1 Dermatology recommended anti-itch lotion Zeasorb®: #1 Dermatologist recommended anti-fungal and prevention product Desenex®: Anti-fungal powder for athlete’s foot Mineral Ice®: Leading pain-relieving gel. |
Buy | - |
Montreux Equity Partners is a growth investment firm focused on investing in commercial stage companies with category leading products, technologies, and services. Montreux Equity Partners looks to invest $10 to $20 million in fast growing companies with $5 to $50 million in revenue. Montreux Equity Partners was formed in 1993 and is headquartered in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 25 of 27 |
| Sector (Life Science) | 8 of 8 |
| Type (Growth Capital) | 2 of 2 |
| State (Tennessee) | 1 of 1 |
| Country (United States) | 24 of 25 |
| Year (2017) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-08-01 |
Colorescience
Carlsbad, California, United States Colorescience is a cosmeceutical company providing natural, mineral-based approach to skin protection and skin health. Colorescience was founded in 2000 and is based in Carlsbad, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-01-31 |
Active Care Group
Kent, United Kingdom Active Care Group provides a national live-in care service for adults and children with spinal cord injuries and neurological conditions. Many of its clients are tetraplegics, requiring a constantly high level of care from live-in personal assistants. Active Care Group is based in Kent, United Kingdom. |
Buy | - |
